Blog
RSS FeedPosted by Michael Wonder on 27 Mar 2019
PBS process improvements webinar information forum
27 March 2019 - The Department of Health will be hosting a webinar on 5 April 2019 to provide industry, ...
Posted by Michael Wonder on 21 Feb 2019
Pharmaceutical Benefits Scheme process improvements webinar information forum
21 February 2019 - The Department of Health will be hosting a webinar to provide industry, consumers and clinicians with ...
Posted by Michael Wonder on 13 Feb 2019
PHARMAC to review its practices following criticism of breast cancer drug funding
13 February 2019 - The government's drug-buying agency has announced it has begun an internal review following a petition and ...
Posted by Michael Wonder on 07 Nov 2018
NHS England in legal battle with American firm over medicine procurement
7 November 2018 - An American pharmaceutical company has launched a legal challenge against NHS England over a procurement process ...
Posted by Michael Wonder on 10 Oct 2018
Digital technology could revolutionise drug reimbursement in Spain
8 October 2018 - Digital technology could play a major role in creating a system that reimburses medicines based on ...
Posted by Michael Wonder on 08 Oct 2018
Revised process for ultra-orphan medicines
8 October 2018 - Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the ...
Posted by Michael Wonder on 02 Oct 2018
New Ministerial discretion guidance for first new brand statutory price reductions
2 October 2018 - Guidance material on requesting Ministerial discretion for first new brand statutory price reductions is now available. ...
Posted by Michael Wonder on 18 Sep 2018
Information forums - streamlining PBS medicines listing processes
18 September 2018 - The Department of Health in collaboration with Medicines Australia will be hosting information forums in both ...
Posted by Michael Wonder on 18 Sep 2018
Changes to TGA/PBAC parallel processing arrangements for biosimilar medicines
18 September 2018 - Submissions requesting the listing of a new biosimilar medicine are no longer eligible to be submitted under ...
Posted by Michael Wonder on 23 Jan 2018
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
23 January 2018 - Although health technology assessment systems base their decision making process either on economic evaluations or comparative clinical ...
Posted by Michael Wonder on 13 Dec 2017
Update on revised process for biosimilars
12 December 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the submission and ...
Posted by Michael Wonder on 01 Dec 2017
FDA aims to expand early approval program for promising drugs
30 November 2017 - Scott Gottlieb speaks before House subcommittee on health. ...
Posted by Michael Wonder on 27 Nov 2017
Revised process for filing CDR submissions and resubmissions
27 November 2017 - The CADTH Common Drug Review is aligning the process for secure file sharing with the pan-Canadian ...
Posted by Michael Wonder on 15 Nov 2017
Revised procedure for the CADTH Common Drug Review resubmissions
13 November 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission requirements ...
Posted by Michael Wonder on 15 Nov 2017
FDA unveils a streamlined path for the authorisation of tumour profiling tests alongside its latest product action
15 November 2017 - The U.S. FDA today authorised Memorial Sloan Kettering Cancer Center’s IMPACT (Integrated Mutation Profiling of Actionable Cancer ...